Best OTC Medication for Sinus Congestion in COVID-19
For a COVID-19 patient with congested sinuses, pseudoephedrine (available OTC in Canada as Sudafed or generic equivalents) is the most effective decongestant option, taken as 60 mg every 4-6 hours as needed for symptom relief. 1
Symptomatic Treatment Approach
Pseudoephedrine is FDA-approved specifically to temporarily relieve sinus congestion and pressure, as well as nasal congestion due to upper respiratory infections. 1
The standard dosing is 60 mg every 4-6 hours, which has been proven effective in both single and multiple doses for reducing nasal congestion through objective measurements of nasal airway resistance. 2
Research demonstrates that pseudoephedrine 60 mg produces statistically significant reduction in nasal congestion compared to placebo, with effects measurable within 3-4 hours and sustained efficacy over multiple days of treatment. 2
Supportive Care Recommendations
COVID-19 patients should receive adequate supportive treatment including rest, nutrition, and fluid support to maintain water-electrolyte balance. 3
For fever accompanying sinus congestion, paracetamol (acetaminophen) is preferred over NSAIDs for COVID-19 patients, taken only while fever and symptoms are present. 4
Patients should drink fluids regularly to avoid dehydration, but no more than 2 liters per day. 4
Safety Considerations
Pseudoephedrine is generally safe with minimal adverse effects—clinical trials showed only 2-4 beats per minute increase in heart rate compared to placebo, with adverse events unrelated to treatment. 2
Monitor for signs of clinical deterioration beyond sinus congestion, particularly respiratory rate (>30 breaths/min in adults) and oxygen saturation (<93% on room air), as these indicate progression to severe disease requiring different management. 3, 5, 6
Critical Pitfall to Avoid
Do not use corticosteroids for symptom management in COVID-19 patients without hypoxia (oxygen saturation ≥93% on room air), as this provides no benefit and causes harm through immunosuppression and increased infection risk. 5, 6
Avoid hydroxychloroquine, azithromycin (unless bacterial coinfection documented), and lopinavir/ritonavir, as these have no efficacy for COVID-19 symptom management and may cause harm. 5, 6
When to Escalate Care
If oxygen saturation drops below 93% or respiratory rate exceeds 30 breaths/min, the patient requires immediate medical evaluation for potential hospitalization and dexamethasone therapy. 5, 6
Progressive worsening of symptoms beyond sinus congestion, particularly shortness of breath or chest tightness, warrants urgent reassessment. 3, 7